TTK Healthcare Limited
NSE: TTKHLTCARE
Prev Close
1145
Open Price
1150.8
Volume
5,522
Today Low / High
1133.2 / 1184.9
52 WK Low / High
1101.05 / 1893.95
Range
1,089 - 1,204
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 1146.8, with a change of 1.8 (0.15721%). The expected target range on the NSE is between 1,089 - 1,204. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.
TTK Healthcare Limited Graph
TTK Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for TTK Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,146.80, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 1,146.80 | 1,158.27 | 1,042.44 - 1,274.09 |
| 1,169.74 | 935.79 - 1,403.68 | ||
| 1,181.20 | 826.84 - 1,535.57 | ||
| Bearish Scenario | 1,146.80 | 1,135.33 | 1,021.80 - 1,248.87 |
| 1,123.86 | 899.09 - 1,348.64 | ||
| 1,112.40 | 778.68 - 1,446.11 |
Overview of TTK Healthcare Limited
ISIN
INE910C01018
Industry
Drug Manufacturers - General
Vol.Avg
6,570
Market Cap
16,204,628,040
Last Dividend
10
Official Website
IPO Date
2010-01-08
DCF Diff
-236.61
DCF
1,391
Financial Ratios Every Investor Needs
Stock Dividend of TTKHLTCARE
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-07-18 | July 18, 25 | 10 | 10 | 2025-07-18 | 2025-08-24 | |
| 2024-07-16 | July 16, 24 | 10 | 10 | 2024-07-17 | 2024-08-23 | |
| 2023-07-18 | July 18, 23 | 10 | 10 | 2023-07-18 | 2023-08-24 | |
| 2022-07-26 | July 26, 22 | 10 | 10 | 2022-07-27 | 2022-08-23 | |
| 2021-08-12 | August 12, 21 | 6 | 6 | 2021-08-14 | 2021-09-07 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 872.75 Cr | 368.92 Cr | 503.83 Cr | 0.5773 | 0.16 Cr | 13.66 Cr | 352.92 Cr | 81.66 Cr | 57.79 | 106.08 Cr | 0.0936 |
| 2024-03-31 | 747.64 Cr | 484.15 Cr | 263.49 Cr | 0.3524 | 1.13 Cr | 13.11 Cr | 24.99 Cr | 62.84 Cr | 44.47 | 99.93 Cr | 0.0841 |
| 2023-03-31 | 725.11 Cr | 347.78 Cr | 377.34 Cr | 0.5204 | 1.32 Cr | 10.46 Cr | 18.68 Cr | 639.71 Cr | 452.73 | 79.68 Cr | 0.8822 |
| 2022-03-31 | 596.07 Cr | 287.02 Cr | 309.06 Cr | 0.5185 | 2.93 Cr | 10.11 Cr | 9.28 Cr | 41.59 Cr | 29.43 | 40.66 Cr | 0.0698 |
| 2021-03-31 | 633.42 Cr | 254.00 Cr | 379.43 Cr | 0.5990 | 2.65 Cr | 9.11 Cr | 6.44 Cr | 46.44 Cr | 32.87 | 37.35 Cr | 0.0733 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 786.49 Cr | 1,281.19 Cr | 216.14 Cr | 1,065.0482 Cr | 24.22 Cr | -762.27 Cr | 108.59 Cr | 80.98 Cr | 0.00 Cr | 0.00 Cr | 11.22 Cr | 210.9231 Cr |
| 2024-03-31 | 10.96 Cr | 1,200.59 Cr | 199.68 Cr | 1,000.9189 Cr | 22.81 Cr | 11.85 Cr | 96.99 Cr | 75.59 Cr | 0.00 Cr | 0.00 Cr | -795.88 Cr | 195.8164 Cr |
| 2023-03-31 | 9.32 Cr | 1,170.11 Cr | 216.73 Cr | 953.3841 Cr | 27.33 Cr | 18.01 Cr | 84.51 Cr | 73.94 Cr | 56.57 Cr | 1.70 Cr | 12.85 Cr | 210.7799 Cr |
| 2022-03-31 | 14.86 Cr | 558.55 Cr | 228.92 Cr | 329.6314 Cr | 22.21 Cr | 7.35 Cr | 78.92 Cr | 80.48 Cr | 90.81 Cr | 1.89 Cr | 15.13 Cr | 220.5344 Cr |
| 2021-03-31 | 9.55 Cr | 494.27 Cr | 199.63 Cr | 294.6464 Cr | 19.14 Cr | 9.59 Cr | 70.30 Cr | 86.12 Cr | 68.47 Cr | 1.81 Cr | 13.17 Cr | 188.7626 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -3.9757 Cr | 20.1034 Cr | -18.0806 Cr | -16.8155 Cr | -1.9529 Cr | 9.0064 Cr | -12.8398 Cr | 81.6569 Cr | 0.4621 Cr | -14.1303 Cr | -11.5988 Cr |
| 2024-03-31 | -4.9433 Cr | 28.4935 Cr | -21.9112 Cr | -15.3267 Cr | 1.6390 Cr | 10.9593 Cr | -10.3834 Cr | 62.8419 Cr | -4.0553 Cr | -14.1303 Cr | -12.4752 Cr |
| 2023-03-31 | -26.0762 Cr | 32.9586 Cr | -12.4263 Cr | -37.7753 Cr | -5.5439 Cr | 9.3203 Cr | -11.6991 Cr | 838.0748 Cr | 5.1439 Cr | -14.1303 Cr | 1.9100 Cr |
| 2022-03-31 | 44.9963 Cr | -30.5473 Cr | -9.1396 Cr | 38.5016 Cr | 5.3094 Cr | 14.8642 Cr | -6.4947 Cr | 57.7787 Cr | 2.7862 Cr | -8.4782 Cr | -16.1207 Cr |
| 2021-03-31 | 96.4211 Cr | -77.2390 Cr | -17.1562 Cr | 94.6884 Cr | 2.0259 Cr | 9.5548 Cr | -1.7327 Cr | 37.0519 Cr | -10.6933 Cr | -4.2391 Cr | 1.3409 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 226.43 Cr | 101.82 Cr | 124.61 Cr | 0.5503 | 0.49 Cr | 13.00 Cr | 9.20 | 20.61 Cr | 0.0574 |
| 2025-03-31 | 209.05 Cr | 7.37 Cr | 121.54 Cr | 0.5814 | 85.14 Cr | 16.15 Cr | 11.43 | 30.61 Cr | 0.0772 |
| 2024-12-31 | 204.74 Cr | 98.03 Cr | 106.71 Cr | 0.5212 | 5.58 Cr | 16.73 Cr | 11.84 | 25.53 Cr | 0.0817 |
| 2024-09-30 | 198.49 Cr | 129.57 Cr | 68.91 Cr | 0.3472 | 6.22 Cr | 17.20 Cr | 12.17 | 25.93 Cr | 0.0867 |
| 2024-06-30 | 207.90 Cr | 133.95 Cr | 73.96 Cr | 0.3557 | 4.86 Cr | 31.58 Cr | 22.35 | 43.70 Cr | 0.1519 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 786.49 Cr | 846.11 Cr | 786.49 Cr | 90.53 Cr | 108.59 Cr | 1,103.89 Cr | 80.98 Cr | 1,281.19 Cr | 216.14 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 792.84 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,038.77 Cr |
| 2024-09-30 | 792.84 Cr | 931.83 Cr | 792.84 Cr | 95.81 Cr | 105.29 Cr | 1,158.46 Cr | 79.33 Cr | 1,266.61 Cr | 227.83 Cr |
| 2024-06-30 | -845.21 Cr | 1,690.42 Cr | 845.21 Cr | 0.00 Cr | 0.00 Cr | 845.21 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 774.94 Cr | 863.76 Cr | 774.94 Cr | -0.45 Cr | 96.99 Cr | 1,077.30 Cr | 75.59 Cr | 1,200.59 Cr | 199.68 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 16.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 16.73 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 17.20 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 31.58 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 18.27 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - General
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Cipla Limited | CIPLA | ₹1,592.80 | ₹1,286,590,545,715.00 | ₹1,574,525.00 |
| Abbott India Limited | ABBOTINDIA | ₹31,875.00 | ₹677,321,437,500.00 | ₹6,991.00 |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO | ₹2,798.80 | ₹474,133,512,800.00 | ₹39,428.00 |
| Gland Pharma Limited | GLAND | ₹1,957.40 | ₹322,493,394,400.00 | ₹430,192.00 |
| Pfizer Limited | PFIZER | ₹5,668.50 | ₹259,320,837,450.00 | ₹24,713.00 |
| Sanofi India Limited | SANOFI | ₹5,230.50 | ₹120,458,415,000.00 | ₹7,436.00 |
| Marksans Pharma Limited | MARKSANS | ₹179.96 | ₹81,551,393,440.00 | ₹681,593.00 |
Key Executives
Gender: male
Year Born: 1968
Gender: male
Year Born: 1961
Gender: male
Year Born: 1965
Gender: Not Specified
Year Born: 1978
Gender: male
Year Born: 1952
Gender: male
Year Born: 1967
Gender: male
Year Born: 1968
Gender: male
Year Born: 1971
Gender: male
Year Born: 1963
Gender: female
Year Born:
FAQs about TTK Healthcare Limited
The CEO is T. T. Raghunathan.
The current price is ₹1,146.80.
The range is ₹1101.05-1893.95.
The market capitalization is ₹1,620.46 crores.
The dividend yield is 0.87%.
The P/E ratio is 25.69.
The company operates in the Healthcare sector.
Overview of TTK Healthcare Limited (ISIN: INE910C01018) is a leading Drug Manufacturers - General in India. With a market capitalization of ₹1,620.46 crores and an average daily volume of 6,570 shares, it operates in the Drug Manufacturers - General. The company last declared a dividend of ₹10.